GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Cyclically Adjusted FCF per Share

Quest Diagnostics (BSP:Q1UE34) Cyclically Adjusted FCF per Share : R$22.26 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Quest Diagnostics's adjusted free cash flow per share for the three months ended in Mar. 2024 was R$1.112. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$22.26 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Quest Diagnostics's average Cyclically Adjusted FCF Growth Rate was 7.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Quest Diagnostics was 33.00% per year. The lowest was 1.60% per year. And the median was 7.20% per year.

As of today (2024-04-28), Quest Diagnostics's current stock price is R$328.82. Quest Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$22.26. Quest Diagnostics's Cyclically Adjusted Price-to-FCF of today is 14.77.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Quest Diagnostics was 23.29. The lowest was 11.42. And the median was 17.23.


Quest Diagnostics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Quest Diagnostics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Cyclically Adjusted FCF per Share Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.02 20.71 20.64 22.04

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.62 20.90 24.22 22.04 22.26

Competitive Comparison of Quest Diagnostics's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted Price-to-FCF falls into.



Quest Diagnostics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quest Diagnostics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.112/129.4194*129.4194
=1.112

Current CPI (Mar. 2024) = 129.4194.

Quest Diagnostics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.781 100.560 2.292
201409 1.362 100.428 1.755
201412 1.964 99.070 2.566
201503 -0.043 99.621 -0.056
201506 2.404 100.684 3.090
201509 2.153 100.392 2.776
201512 2.382 99.792 3.089
201603 1.361 100.470 1.753
201606 3.062 101.688 3.897
201609 2.749 101.861 3.493
201612 2.690 101.863 3.418
201703 1.708 102.862 2.149
201706 2.695 103.349 3.375
201709 3.345 104.136 4.157
201712 2.836 104.011 3.529
201803 1.262 105.290 1.551
201806 3.323 106.317 4.045
201809 4.744 106.507 5.765
201812 2.012 105.998 2.457
201903 3.219 107.251 3.884
201906 3.345 108.070 4.006
201909 3.052 108.329 3.646
201912 2.656 108.420 3.170
202003 2.968 108.902 3.527
202006 5.207 108.767 6.196
202009 15.195 109.815 17.908
202012 7.169 109.897 8.443
202103 13.462 111.754 15.590
202106 7.444 114.631 8.404
202109 9.967 115.734 11.146
202112 7.623 117.630 8.387
202203 8.575 121.301 9.149
202206 6.914 125.017 7.157
202209 8.532 125.227 8.818
202212 4.265 125.222 4.408
202303 -0.761 127.348 -0.773
202306 7.238 128.729 7.277
202309 2.209 129.860 2.202
202312 9.953 129.419 9.953
202403 1.112 129.419 1.112

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Quest Diagnostics  (BSP:Q1UE34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Quest Diagnostics's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=328.82/22.26
=14.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Quest Diagnostics was 23.29. The lowest was 11.42. And the median was 17.23.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Quest Diagnostics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (BSP:Q1UE34) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines